益樂鉑定凍晶注射劑５毫克/毫升
Country: Taiwan
Language: Chinese
Source: 衛生福利部食品藥物管理署 (Ministry of Health and Welfare, Food And Drug Administration)
Patient Information leaflet
(PIL)
21-12-2020
Public Assessment Report
(PAR)
30-03-2020
Some documents for this product are not currently available, you can send a request to our customer service and we will notify you as soon as we are able to obtain them.
Send request.
Send request.
Active ingredient:
OXALIPLATIN
Available from:
賽諾菲股份有限公司 台北市松山區復興北路337號12、13、14樓 (97168356)
ATC code:
L01XA03
Pharmaceutical form:
凍晶注射劑
Composition:
OXALIPLATIN (1012001600) MG
Units in package:
盒裝;;盒裝;;小瓶;;小瓶
Class:
製 劑
Prescription type:
限由醫師使用
Manufactured by:
SANOFI-AVENTIS FRANCE 1-13, BOULEVARD ROMAIN ROLLAND 75014 PARIS, FRANCE FR
Therapeutic area:
oxaliplatin
Therapeutic indications:
和5-fluorouracil (5-FU)和folinic acid (FA)併用，作為 -第三期結腸癌(Duke'sC)原發腫瘤完全切除手術後的輔助療法。-治療轉移性結腸直腸癌。Eloxatin與Capecitabine併用可用於局部晚期及復發/轉移性胃癌之治療。
Product summary:
註銷日期: 2014/10/07; 註銷理由: 自請註銷; 有效日期: 2014/08/05; 英文品名: ELOXATIN 5 MG/ML POWDER FOR SOLUTION FOR INFUSION
Authorization status:
已註銷
Authorization date:
1999-08-05
